Sobhan Oncology Pharmaceutical Company (DSANKO) financial ratios
Every ratio computed for this symbol, period by period, beside its industry and its own board
- Ticker
- DSANKO
- Industry
- Pharmaceuticals
- Market
- Iran Fara Bourse
Latest periods
| Item | Report to 1404/09/30 | Report to 1403/09/30 | Report to 1402/09/30 | Report to 1401/09/30 |
|---|---|---|---|---|
| P/E TTM | 53.93 | 65.70 | 201.15 | 20.83 |
| P/S TTM | 1.13 | 1.69 | 1.70 | 2.23 |
| P/B | 1.46 | 5.44 | 6.28 | 5.20 |
| Gross margin TTM | 48.0% | 50.3% | 43.0% | 52.7% |
| Net margin TTM | 2.1% | 2.5% | 0.8% | 10.7% |
| ROA TTM | 0.8% | 1.4% | 0.5% | 7.1% |
| ROE TTM | 2.7% | 8.2% | 3.1% | 25.0% |
| Collection period TTM | 519 days | 442 days | 343 days | 335 days |
| Inventory period TTM | 117 days | 118 days | 81 days | 155 days |
| PEG TTM | - | 1.76 | - | 5.03 |
| PEGY TTM | - | 1.65 | - | 2.29 |